BERNARDO, MARIA ESTER
 Distribuzione geografica
Continente #
AS - Asia 3.536
EU - Europa 3.397
NA - Nord America 2.098
SA - Sud America 981
AF - Africa 81
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.107
Nazione #
US - Stati Uniti d'America 1.993
RU - Federazione Russa 1.985
SG - Singapore 1.389
CN - Cina 1.065
BR - Brasile 811
SE - Svezia 468
HK - Hong Kong 445
VN - Vietnam 351
IT - Italia 307
FR - Francia 171
DE - Germania 127
GB - Regno Unito 81
AR - Argentina 73
IN - India 61
FI - Finlandia 58
NL - Olanda 56
CA - Canada 54
AT - Austria 42
ID - Indonesia 38
MX - Messico 35
BD - Bangladesh 30
EC - Ecuador 30
PL - Polonia 28
IQ - Iraq 27
ZA - Sudafrica 26
TR - Turchia 19
UA - Ucraina 17
SA - Arabia Saudita 16
VE - Venezuela 16
CO - Colombia 15
JP - Giappone 15
UZ - Uzbekistan 14
ES - Italia 13
LT - Lituania 13
EG - Egitto 11
KE - Kenya 11
MA - Marocco 11
PY - Paraguay 11
IL - Israele 9
NP - Nepal 9
AZ - Azerbaigian 7
CL - Cile 7
DO - Repubblica Dominicana 7
IE - Irlanda 7
PE - Perù 7
UY - Uruguay 7
JO - Giordania 6
PK - Pakistan 6
CR - Costa Rica 5
DZ - Algeria 5
IR - Iran 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CZ - Repubblica Ceca 4
EU - Europa 4
TN - Tunisia 4
BE - Belgio 3
BO - Bolivia 3
LB - Libano 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CY - Cipro 2
ET - Etiopia 2
GR - Grecia 2
JM - Giamaica 2
MD - Moldavia 2
MT - Malta 2
NG - Nigeria 2
PT - Portogallo 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
EE - Estonia 1
FJ - Figi 1
GA - Gabon 1
GE - Georgia 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
NA - Namibia 1
NR - Nauru 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TL - Timor Orientale 1
TV - Tuvalu 1
TW - Taiwan 1
Totale 10.107
Città #
Singapore 530
Moscow 475
Hong Kong 445
Dallas 338
Ashburn 275
Shanghai 239
San Jose 206
Hefei 161
Beijing 144
Lauterbourg 139
Lawrence 138
Princeton 138
Ho Chi Minh City 123
Milan 101
New York 98
Hanoi 76
São Paulo 65
Los Angeles 63
Helsinki 37
Boardman 33
Nuremberg 29
Dronten 26
Orem 26
Santa Clara 26
Rio de Janeiro 25
Rome 25
Montreal 24
Council Bluffs 22
Guangzhou 22
Haiphong 22
London 22
Warsaw 22
Munich 21
Frankfurt am Main 20
Chennai 19
Curitiba 18
Chicago 16
Johannesburg 16
Tokyo 15
Brasília 14
Brooklyn 14
Da Nang 14
Houston 14
Shenzhen 14
Tashkent 14
Denver 13
Guarulhos 13
Poplar 13
Turku 13
Vienna 13
Cesano Boscone 12
Mexico City 12
Stockholm 12
Toronto 12
Boston 11
Guayaquil 11
Hải Dương 11
Porto Alegre 11
Seattle 11
Atlanta 10
Belo Horizonte 10
Columbus 10
Hangzhou 10
Monza 10
Nairobi 10
Salvador 10
Brescia 9
San Francisco 9
Baghdad 8
Lappeenranta 8
Manchester 8
Mumbai 8
Phoenix 8
Recife 8
San Diego 8
The Dalles 8
Turin 8
Ankara 7
Boydton 7
Cumming 7
Ipatinga 7
Quito 7
Reston 7
Sorocaba 7
Amman 6
Cairo 6
Fortaleza 6
Itaquaquecetuba 6
Jakarta 6
Joinville 6
Montevideo 6
Phủ Lý 6
Pune 6
Querétaro 6
Sumaré 6
Thái Bình 6
Uberlândia 6
Viamão 6
Amsterdam 5
Asunción 5
Totale 4.795
Nome #
Rapamycin-Based GvHD Prophylaxis Is Effective in T-Cell Replete Unmanipulated Haploidentical Peripheral Stem Cell Transplantation for Advanced Haematological Malignancies: Results in 46 Patients 213
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access 161
A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease 145
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency 135
Hematopoietic stem-and progenitor-cell gene therapy for hurler syndrome 133
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease 129
Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy 126
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome 123
Access to gene therapy for rare diseases when commercialization is not fit for purpose 118
An innovative platform approach for the development of ex-vivo gene therapies for the treatment of lysosomal storage diseases with skeletal involvement 117
Peripheral blood stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series 116
A GLB1 transgene with enhanced therapeutic potential for the preclinical development of ex-vivo gene therapy to treat mucopolysaccharidosis type IVB 114
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency 113
An early-senescence state in aged mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro-inflammatory program 106
Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity 105
Wiskott–Aldrich syndrome: Oral findings and microbiota in children and review of the literature 105
Familial platelet disorder with propensity to acute myelogenous leukemia: Genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies 104
Up to 10.5 Years of Follow-Up in 17 Subjects Treated with Hematopoietic Stem and Progenitor Cell Lentiviral Gene Therapy for Wiskott-Aldrich Syndrome 99
Pioglitazone as a novel therapeutic approach in chronic granulomatous disease 99
Assessment of human herpesvirus-6 infection in mesenchymal stromal cells ex vivo expanded for clinical use 97
Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the Art 95
Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report 93
Bone Marrow-Derived Mesenchymal Stromal Cell Intra-Fistular Injections Induce An Up-Regulation Of Foxp3+ Regulatory T-Cells In Patients With Crohn’s Disease 92
Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: Further insights in the search for a fatal calf serum substitute 91
Allogeneic hematopoietic stem cell transplantation in thalassemia major: Results of a reduced-toxicity conditioning regimen based on the use of treosulfan 90
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency 89
Allogeneic hematopoietic stem cell transplantation may restore gluten tolerance in patients with celiac disease 88
Adult autoimmune enteropathy treated with autologous bone marrow-derived mesenchymal stromal cells 87
Evidence of Treatment Benefits in Patients with Mucopolysaccharidosis Type I-Hurler in Long-term Follow-up Using a New Magnetic Resonance Imaging Scoring System 87
Haematopoietic stem cell gene therapy in inborn errors of metabolism 86
Bone marrow-derived mesenchymal stromal cells (MSC) locally injected for refractory fistulizing Crohn’s disease modulate immunoglobulin production 86
A low thymic function is associated with leukemia relapse in children given T-cell-depleted HLA-haploidentical stem cell transplantation 85
A new enzyme-linked immunosorbent assay for a total anti-T lymphocyte globulin determination: Development, analytical validation, and clinical applications 84
Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated BCGitis 84
Autologous bone marrow-derived mesenchymal stem cell infusion in crohn's disease patients with fistulas 83
Biological, functional and genetic characterization of bone marrow-derived mesenchymal stromal cells from pediatric patients affected by acute lymphoblastic leukemia 83
Chromosome anomalies in bone marrow as primary cause of aplastic or hypoplastic conditions and peripheral cytopenia: Disorders due to secondary impairment of RUNX1 and MPL genes 83
The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy 82
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: Evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity 81
Cannabinoid receptor 2 as antiobesity target: Inflammation, fat storage, and browning modulation 81
Long-Term Effects of Atidarsagene Autotemcel for Metachromatic Leukodystrophy 80
Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs. 79
Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation 78
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties 74
Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study 71
Cord blood transplantation in childhood 69
Safety and efficacy of mesenchymal stromal cell therapy in autoimmune disorders 68
Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future 68
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia 67
The human leucocyte antigen-G 14-basepair polymorphism correlates with graft-versus-host disease in unrelated bone marrow transplantation for thalassaemia 67
Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis. 67
Familial myelodysplastic syndromes, monosomy 7/trisomy 8, and mutator effects 66
Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress 66
Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells 66
In-vivo T-regs generation by rapamycin-mycophenolate-ATG as a new platform for GvHD prophylaxis in T-cell repleted unmanipulated haploidentical peripheral stem cell transplantation: results in 59 patients 65
Role of ex vivo Expanded Mesenchymal Stromal Cells in Determining Hematopoietic Stem Cell Transplantation Outcome 64
Generation of mesenchymal stromal cells in the presence of platelet lysate: A phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors 63
MSCs in Pediatric Hematopoietic Stem Cell Transplantation (Chapter 26) 62
The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group 62
Current and Future Perspective in Hematopoietic Stem Progenitor Cell-gene Therapy for Inborn Errors of Metabolism 61
The Role of Conditioning in Hematopoietic Stem-Cell Gene Therapy 61
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major 61
γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes 61
Ex vivo expansion of mesenchymal stromal cells 60
Effects Of Bone Marrow-Derived Mesenchymal Stromal Cells Infused In Fistulas Of Patients With Perianal Crohn’s Disease On Serum Cytokine Pattern, Salivary Iga Production, And Circulating Lymphocyte Subsets 59
How I treat relapsed childhood acute lymphoblastic leukemia 59
Cord blood transplantation in children with haematological malignancies 58
Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantation 58
Mesenchymal stromal cells and chronic inflammatory bowel disease 58
Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar) 57
Mesenchymal Stromal Cells: Role in the BM Niche and in the Support of Hematopoietic Stem Cell Transplantation 57
Mesenchymal stromal cells: A novel treatment modality for tissue repair 56
Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia 56
Human bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms 56
Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation 56
Bone Marrow-Derived Mesenchymal Stromal Cells Locally Injected Induce An Up-Regulation Of Both Circulating And Mucosal Foxp3+ Regulatory T-Cells In Patients With Perianal Crohn’s Disease 54
Multiparametric Whole Blood Dissection: A one-shot comprehensive picture of the human hematopoietic system 54
Low percentages of circulating CD8+/CD45RA+ human T lymphocytes expressing β7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation 54
Successful Treatment With Ledipasvir/Sofosbuvir in an Infant With Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency With HCV Allowed Gene Therapy with Strimvelis 54
Transgenic expression of IL-10 by lentiviral vectors for increasing the anti-inflammatory efficacy of mesenchymal stromal cells 53
Immunomodulatory properties of MSCs (Chapter 7) 53
Bone marrow-derived mesenchymal stromal cells locally injected for refractory fistulizing Crohn’s disease modulate serum immunoglobulins, secretory IgA, and antibody production 53
Bone osteoblastic and mesenchymal stromal cells lack primarily tumoral features in multiple myeloma patients 53
Gene therapy for mucopolysaccharidoses: In vivo and ex vivo approaches 10 Technology 1004 Medical Biotechnology 53
Co-transplantation of ex-vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem cell transplantation 53
Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources 52
Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy 50
Mesenchymal stromal cells: a novel and effective strategy for facilitating engraftment and accelerating hematopoietic recovery after transplantation? 50
MPSI Manifestations and Treatment Outcome: Skeletal Focus 49
Haematopoietic stem cell transplantation for patients with Thalassemia 49
Successful treatment of fistulizing crohn's disease with local infusions of autologous bone marrow-derived mesenchymal stem cells 49
Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine? 49
Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I 49
Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I 49
Lentiviral gene therapy corrects platelet phenotype and function in Wiskott-Aldrich patients 48
Treatment of fistulizing Crohn’s disease with local infusions of autologus bone marrow-derived mesenchymal stromal cells 48
Mesenchymal stromal cells: Sensors and switchers of inflammation 48
Mesenchymal stromal cells and hematopoietic stem cell transplantation 48
Single-cell cloning of human, donor-derived antileukemia T-cell lines for in vitro separation of graft-versus-leukemia effect from graft-versus-host reaction 48
Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation 48
Totale 7.692
Categoria #
all - tutte 62.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.484


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 1 0 0
2021/202285 0 0 0 43 4 7 4 3 15 1 4 4
2022/2023866 313 147 47 4 31 124 13 31 97 6 36 17
2023/2024435 20 23 30 47 36 45 84 32 3 12 31 72
2024/20252.409 317 48 99 36 67 154 253 209 449 325 228 224
2025/20266.410 472 583 479 1.072 491 198 571 489 1.801 254 0 0
Totale 10.311